Projects
News
Contacts
Our work
Discovery and development of small molecule modulators of Cytochrome P450 enzymes
read more
Our goal
To build a robust drug discovery platform addressing unmet medical needs across multiple therapeutic areas
read more
Our mission
To translate breakthrough science into life-changing pharmaceutical solutions for global healthcare
read more
Projects
Aldosterone synthase inhibitor
read more
Satellite R&D Platform
read more
Aldosterone synthase inhibitor
by Target Medicals
Satellite R&D Platform
News and Events
29 December 2025
Target Medicals raised a Series A round
Target Medicals has secured a follow-on investment deal from Unicorn Capital Partners
01 February 2022
Target Medicals closes a seed-stage venture deal
Unicorn Capital Partners VC and AstraZeneca invest in Target Medicals
05 May 2020
Target Medicals is a finalist of the Start-Up Stadium.
Target Medicals Group is among finalists of the Start-Up Stadium event at the 2020 BIO International Convention Digital
All news and events